去年，Insulet Corp表現最佳的業務類別U.S.Omnipod的營收達到1.92B美元。United States的營收貢獻最高，去年達到1.95B美元。最近一個季度，截至2026-06-30，Insulet Corp表現最佳的業務類別U.S.Omnipod的營收達到544.10M美元。United States的營收貢獻最高，達到549.90M美元。

業務

營業收入

佔比

年報

年報

單季報

U.S.Omnipod

International Omnipod

Drug Delivery

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

U.S.Omnipod

1.92B(70.89%)

1.51B(72.86%)

1.25B(73.71%)

884.80M(67.79%)

651.50M(59.29%)

526.90M(58.26%)

420.40M(56.95%)

323.53M(57.38%)

271.60M(58.56%)

301.67M(82.20%)

International Omnipod

754.30M(27.85%)

523.40M(25.27%)

410.10M(24.16%)

363.00M(27.81%)

359.90M(32.75%)

308.00M(34.06%)

253.10M(34.29%)

172.02M(30.51%)

119.95M(25.86%)

--(--)

Drug Delivery

34.10M(1.26%)

38.90M(1.88%)

36.00M(2.12%)

57.50M(4.41%)

87.40M(7.95%)

69.50M(7.68%)

64.70M(8.76%)

68.28M(12.11%)

72.22M(15.57%)

65.31M(17.80%)

地區

營業收入

佔比

年報

年報

單季報

United States

All Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

United States

1.95B(72.15%)

1.55B(74.73%)

1.29B(75.84%)

942.30M(72.19%)

738.90M(67.25%)

596.40M(65.94%)

485.10M(65.71%)

391.80M(69.49%)

343.81M(74.14%)

295.10M(80.41%)